Transgenic(TG) (mRen-2) rats overexpressing the mouse renin gene de'/> Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats
首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats
【2h】

Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats

机译:下调转基因(mRen-2)27大鼠的主动脉和心脏AT1受体基因表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">Transgenic(TG) (mRen-2) rats overexpressing the mouse renin gene develop fulminant hypertension and cardiac hypertrophy. Since the activation of AT1 receptor by angiotensin II is involved in blood pressure regulation, cardiac performance and myocardial growth, we investigated the biological effects of angiotensin II and the regulation of the AT1 receptor in the heart and aorta of TGR (mRen-2)27 rats in comparison to control animals.Contraction studies on isolated cardiac muscle strips reveal that angiotensin II exerts no positive inotropic effect on the left ventricular myocardium of both, transgenic and control rats. In contrast, angiotensin II leads via AT1 receptor activation in the left atrium of control rats to a significant contraction (130±5% of basal contraction) which is not detectable in left atrium preparations of the transgenic animals. Furthermore, AT1 receptor activation causes a profound contraction of aortic rings isolated from control rats amounting to 1.39±0.2 mN mg−1 wet weight, whereas aortic rings from TGR (mRen-2)27 rats contract only minimally upon angiotensin II stimulation (0.2±0.02 mN mg−1 wet weight).These altered physiological responses of angiotensin II in the transgenic rats are in part due to a marked down-regulation of the AT1 receptor in atrial, ventricular and aortic tissue of these transgenic animals in comparison to control Sprague-Dawley rats, as shown by radioligand binding assays and quantitative polymerase chain reaction (PCR) experiments. The AT1 receptor density Bmax in the left atrium was 1.3±0.08 fmol mg−1 protein in control rats (KD 1.1±0.18 nmol l−1) and 0.94±0.15 fmol mg−1 protein (KD 2.1±0.3 nmol l−1. In the aorta Bmax values were 15.1±0.5 fmol mg−1 protein (KD 1.9±0.27 nmol l−1) for control rats and 11.3±0.76 fmol mg−1 protein (KD 1.9±0.27 nmol l−1) for the TGR(mRen-2)27 rats AT1 receptor mRNA was reduced in the transgenic animals to 46±3% in the left atrium, 50±11% in the left ventricle and 40±3% in the aorta, respectively.Together, the AT1 receptor is down-regulated in TGR (mRen-2)27 rats in comparison to wildtype Sprague Dawley rats leading to a profoundly decreased response of cardiac and aortic tissue upon stimulation with angiotensin II.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 过表达小鼠肾素基因的转基因(TG)(mRen-2)大鼠发展为暴发性高血压和心脏肥大。由于血管紧张素II对AT1受体的激活涉及血压调节,心脏性能和心肌生长,因此我们研究了血管紧张素II的生物学效应以及对TGR(mRen-2)27的心脏和主动脉的AT1受体的调节。 对离体心肌条的收缩研究表明,血管紧张素II对转基因和对照大鼠的左心室心肌均无正性肌力作用。相比之下,血管紧张素II通过控制大鼠左心房中的AT1受体激活导致明显的收缩(基础收缩的130±5%),这在转基因动物的左心房制剂中是无法检测到的。此外,AT1受体的激活导致从对照组大鼠分离出的主动脉环明显收缩,湿重为1.39±0.2 mN mg -1 ,而TGR(mRen-2)27大鼠的主动脉环收缩最小。受到血管紧张素II刺激(湿重0.2±0.02 mN mg -1 )。 这些转基因大鼠血管紧张素II的生理反应改变部分是由于明显降低了与对照Sprague-Dawley大鼠相比,这些转基因动物在心房,心室和主动脉组织中对AT1受体的调节作用如放射性配体结合测定法和定量聚合酶链反应(PCR)实验所示。对照组大鼠左心房AT1受体密度Bmax为1.3±0.08upfmol mg -1 蛋白(KD 1.1±0.18 nmol l -1 )和0.94±0.15 fmol mg −1 蛋白(KD 2.1±0.3 nmol l -1 。主动脉中Bmax值为15.1±0.5 fmol mg -1 蛋白(对照大鼠的KD 1.9±0.27 nmol l -1 )和11.3±0.76 fmol mg -1 蛋白(KD 1.9±0.27 nmol l -1 对于TGR(mRen-2)27大鼠,AT1受体的mRNA在转基因动物中分别降低至左心房的46±3%,左心室的50±11%和主动脉的40±3%。 与野生型Sprague Dawley大鼠相比,TGR(mRen-2)27大鼠中的AT1受体被下调,导致血管紧张素II刺激后心脏和主动脉组织的反应大大降低。 / li>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号